Phase 2 Clinical Trials
98-C-0074
A Phase II Study of Intravenous RMP-7 and Carboplatin in Childhood
Brain Tumors
Principal Investigator: Dr. Katherine Warren
01-C-0222:
A Phase II Randomized, Cross-Over, Double-Blinded, Placebo-Controlled
Trial of the Farnesyltransferase Inhibitor R115777 in Pediatric
Patients with Neurofibromatosis Type 1 and Progressive Plexiform
Neurofibromas
Principal Investigator: Dr.Brigitte Widemann
01-C-0030:
Short-Course EPOCH-Rituximab for Untreated CD-20+
HIV-Associated Lymphomas
Principal Investigator: Alan Wayne
04-C-0173:
Phase II Study Of UCN-01 In Relapsed Or Refractory Systemic Anaplastic
Large Cell And Mature T-Cell Lymphomas
Principal Investigator: Alan Wayne
Also see Pharmacology and Experimental Therapeutics
Section
Last Updated:
October 3, 2006
NCI
Home Page|| NIH Home Page
© 2002-2003, Pediatric Oncology Branch, Center for Cancer Research,
National Cancer Institute
|